Puerto Rico Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
January 7, 2015
101 Pages - SKU: BMI5432591
Countries covered: Puerto Rico

Puerto Rico Pharmaceuticals and Healthcare Report Q1 2015

BMI View: The trend of pharmaceutical plant closures in Puerto Rico will lead to increasingunemployment and deterioration of the island's economy over the short term, as companies are forced toconsolidate their manufacturing operations in the face of financial challenges. In the long term, Puerto Ricoremains an attractive destination for medicine production, as new and renewed investments will continue toenter the country.

Headline Expenditure Projections

Pharmaceuticals: USD3.020bn in 2013 to USD3.023bn in 2014; +0.1%. Forecast slightly downcompared with Q414.

Healthcare: USD7.76bn in 2013 to USD8.02bn in 2014; +3.4%. Forecast slightly down comparedwith Q414.



More Prescription Drugs reports by Business Monitor International

Namibia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Namibia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Recent comments by the public relations officer of the Ministry of Health and Social Services,Ester Paulus, that ...
Moldova Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Moldova Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Moldovan pharmaceutical market presents limited opportunities for investors in the shortterm, but with the country opening ...
Ghana Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Ghana Pharmaceuticals and Healthcare Report Q1 2015BMI View: We anticipate that the continuing roll-out of biometric registration and expansion of thecommunity-based health planning and services ...
Central America Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Central America Pharmaceuticals and Healthcare Report Q1 2015BMI View: Central America will continue to offer revenue-generating opportunities for multinationalpharmaceutical companies. An ageing population, favourable tax ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!